ghk cu lozenges GHK-Cu Oral Liposomal Copper GHK

Reconstituted solutions are generally advised to be stored at low temperature, shielded from light, and used within a defined experimental window to maintain potency and limit microbial risk, in accordance with local lab practices

Prost Biotech | Metabolic Health Education

Hypothetical Dosing Considerations While no evidence-based cagrilintide dosage with retatrutide protocol exists, theoretical frameworks based on monotherapy data suggest several principles that would likely apply: Conservative Approach Principles: Start with minimal doses Perhaps 0.3 mg cagrilintide + 2 mg retatrutide weekly Extended titration periods 16-24 weeks to reach target doses instead of standard 8-12 weeks Alternating escalation Increase one compound while holding the other stable Frequent monitoring Weekly check-ins during initial phases Lower maximum doses Perhaps 1.2 mg cagrilintide + 8 mg retatrutide rather than maximum monotherapy doses These suggestions remain purely speculative and should not be interpreted as clinical recommendations

Always use a sterile syringe and needle when drawing from the vial to prevent contamination